Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-[5-methanesulfonylamino-2-(4-aminophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-(3,3,3-trifluoro-1-isopropyl-2-oxopropyl)acetamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
A synthetic small molecule with the molecular formula C19H22F3N5O5S and a molecular weight of approximately 489.47 g/mol[1][2][6]. It is also known by the code name TFI and DrugBank ID DB03202. The compound contains a pyrimidine core substituted with methanesulfonamide and aminophenyl groups as well as a trifluoromethylated isopropoxy acetamide side chain. There are no approved therapeutic indications or clinical trial data available for this compound; it appears to be an experimental or research chemical without established pharmacological use in humans[6]. Its mechanism of action has not been characterized in public databases.
- Other names
- 2-(5-methanesulfonylamino-2-(4-aminophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl)-N-(3,3,3-trifluoro-1-isopropyl-2-oxopropyl)acetamide2-[5-methanesulfonamido]-2-(4'-aminophenyl)-6(1H)-oxo-pyrimidin-N-[3S]-trifluoroisopropoxyacetate(R)-RETRO-thiorphanJWSWTHSJMGVOKE-HNNXBMFYSA-N
Beyond the preview
Go deeper on 2-[5-methanesulfonylamino-2-(4-aminophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-(3,3,3-trifluoro-1-isopropyl-2-oxopropyl)acetamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-[5-methanesulfonylamino-2-(4-aminophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-(3,3,3-trifluoro-1-isopropyl-2-oxopropyl)acetamide.